Publication: Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic
Issued Date
2020-06-01
Resource Type
ISSN
15217035
15216616
15216616
Other identifier(s)
2-s2.0-85084738239
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Clinical Immunology. Vol.215, (2020)
Suggested Citation
Amin Gasmi, Sadaf Noor, Torsak Tippairote, Maryam Dadar, Alain Menzel, Geir Bjørklund Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic. Clinical Immunology. Vol.215, (2020). doi:10.1016/j.clim.2020.108409 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/56202
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic
Other Contributor(s)
Abstract
© 2020 Elsevier Inc. It is an ugly fact that a significant amount of the world's population will contract SARS-CoV-II infection with the current spreading. While a specific treatment is not yet coming soon, individual risk assessment and management strategies are crucial. The individual preventive and protective measures drive the personal risk of getting the disease. Among the virus-contracted hosts, their different metabolic status, as determined by their diet, nutrition, age, sex, medical conditions, lifestyle, and environmental factors, govern the personal fate toward different clinical severity of COVID-19, from asymptomatic, mild, moderate, to death. The careful individual assessment for the possible dietary, nutritional, medical, lifestyle, and environmental risks, together with the proper relevant risk management strategies, is the sensible way to deal with the pandemic of SARS-CoV-II.